Zantac » What You Need to Know
The U.S. Food and Drug Administration (FDA) on April 1 requested that manufacturers withdraw all prescription and over-the-counter Zantac drugs from the market immediately. This recall stems from an ongoing investigation that Zantac contains a contaminant called N-Nitrosodimethylamine (NDMA).
The FDA released a statement:
The agency has determined that the impurity in some Zantac (ranitidine) products increases over time and when stored at higher than room temperatures … may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S.
You can read more about the recall from the FDA here.
Zantac was recalled because NDMA has been associated with certain cancers such as breast, testicular, intestinal, esophageal and pancreatic.
NDMA is what’s called a probable human carcinogen (a substance that could cause cancer). The FDA became aware of independent laboratory testing that found NDMA in ranitidine in the summer of 2019. Low levels of NDMA are commonly ingested. For example, NDMA may be found in food and water. But low levels would probably not lead to an increase in the risk of cancer. However, sustained higher levels of exposure may increase the risk of cancer in humans, according to the FDA.
What is Zantac?
Zantac is an antihistamine and antacid. It’s traditionally used to treat or prevent heartburn and indigestion. It’s also used to treat stomach ulcers and gastroesophageal reflux disease (GERD), and other conditions that cause too much stomach acid.
Zantac (ranitidine) works by blocking the production of acid by acid-producing cells in the stomach that help to prevent and heal inflammation and ulcers. Zantac is an H2 (histamine-2) blocker in the drug class of H2 antagonist.
Why was Zantac Recalled?
All Zantac products were recalled by the FDA due to the presence of NDMA, which is a contaminant heavily linked to many types of cancer. The active ingredient in Zantac, ranitidine, helps to increase natural gut bacteria, which helps to reduce nitrates into nitrites. But nitrites are unstable compounds that can sometimes turn into NDMA.
What Types of Cancer Have Been Linked to Zantac?
Studies suggest NDMA exposure from ranitidine has been linked to a multitude of serious cancers including:
- Breast Cancer
- Testicular Cancer
- Esophageal Cancer
- Prostate Cancer
- Thyroid Cancer
- Pancreatic Cancer
I Took Zantac, Do I need a Lawyer?
Thousands of lawsuits across the country have been filed against Zantac’s makers that allege the companies failed to do the research about the cancer risk associated with Zantac, and then failed to warn doctors or patients about the increased risks that were linked to Zantac by multiple independent studies since the 1980s. These cases allege that the makers of Zantac knowingly produced, marketed, and sold a dangerous drug, and placed profits over the safety of millions of people when they marketed a defective drug.
If you used a minimum of 300 mg of Zantac (ranitidine) a week for at least one year or longer, have been diagnosed with cancer, and it’s been no more than five years since your last Zantac (ranitidine) exposure, an experienced litigation attorney may be able to help you get the compensation you deserve.
We also help pregnant women and/or children who were exposed to Zantac for at least six months.
We have nearly 40 years of experience and have assisted clients with a wide range of defective medical devices, dangerous drugs and other products.
If you or a loved one has been diagnosed with cancer after using Zantac, contact us today. Please fill out our contact form to tell us about your case, or call us at 706-354-4000 to set up a free consultation.
We have offices in Atlanta, Athens, and Lake Oconee and we handle cases throughout the United States.
DISCLAIMER: The U.S. Food and Drug Administration is advising consumers who take Zantac, or generic forms of ranitidine, to stop taking the drug following research linking it to NDMA. The FDA also requested for the immediate removal of all prescription and over the counter (OTC) ranitidine products from the market. As with any medication, it’s best to consult with a doctor or other healthcare professional before abruptly stopping use. The content on BBGA’s website is intended to provide helpful information for the general public. It is made available with the understanding that BBGA is not engaged in rendering health, medical, psychological, or any other personal healthcare advice. If you’re currently taking Zantac or any other product containing ranitidine, please consult with your healthcare provider.